These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 10468183)

  • 1. Post-liver transplantation lymphoproliferative disorders with and without infusions of donor bone marrow cells.
    Restrepo A; Albrecht F; Raez LE; Fernandez HF; Nassiri M; Byrne G; Cassileth PA
    Crit Rev Oncog; 1999; 10(3):239-45. PubMed ID: 10468183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Posttransplant lymphoproliferative disorders in transplant recipients.
    Timurağaoğlu A; Uğur-Bilgin A; Colak D; Tuncer M; Gölbaşi I; Hazar V; Kiliçarsłan B; Undar L; Demirbaş A
    Transplant Proc; 2006 Mar; 38(2):641-5. PubMed ID: 16549195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphoma after solid organ transplantation: risk, response to therapy, and survival at a transplantation center.
    Knight JS; Tsodikov A; Cibrik DM; Ross CW; Kaminski MS; Blayney DW
    J Clin Oncol; 2009 Jul; 27(20):3354-62. PubMed ID: 19451438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphoproliferative disorders following allogeneic bone marrow transplantation: the Vancouver experience.
    Micallef IN; Chhanabhai M; Gascoyne RD; Shepherd JD; Fung HC; Nantel SH; Toze CL; Klingemann HG; Sutherland HJ; Hogge DE; Nevill TJ; Le A; Barnett MJ
    Bone Marrow Transplant; 1998 Nov; 22(10):981-7. PubMed ID: 9849695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Posttransplant lymphoproliferative disorder: morphological picture and diagnostic difficulties.
    Ziarkiewicz-Wróblewska B; Górnicka B; Suleiman W; Ołdakowska-Jedynak U; Wróblewski T; Bogdańska M; Ziółkowski J; Nowacka-Cieciura E; Foroncewicz B; Pileri SA; Durlik M; Paczek L; Krawczyk M; Wasiutyński A
    Transplant Proc; 2006; 38(1):168-72. PubMed ID: 16504694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complete immunosuppressive withdrawal as a uniform approach to post-transplant lymphoproliferative disease in pediatric liver transplantation.
    Hurwitz M; Desai DM; Cox KL; Berquist WE; Esquivel CO; Millan MT
    Pediatr Transplant; 2004 Jun; 8(3):267-72. PubMed ID: 15176965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management and outcome of liver recipients with post-transplant lymphoproliferative disease.
    Glez-Chamorro A; Jimenez C; Moreno-Glez E; Glez-Pinto I; Loinaz C; Gomez R; Garcia I; Alonso O; Palma F; Grande C
    Hepatogastroenterology; 2000; 47(31):211-9. PubMed ID: 10690611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-transplant lymphoproliferative disorders after live donor renal transplantation.
    Jain M; Badwal S; Pandey R; Srivastava A; Sharma RK; Gupta RK
    Clin Transplant; 2005 Oct; 19(5):668-73. PubMed ID: 16146560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Autologous stem-cell transplantations in children with non-Hodgkin lymphomas].
    Wójcik B; Kowalczyk JR; Chybicka A; Wachowiak J; Drabko K; Zaucha-Prazmo A; Choma M; Gorczyńska E; Toporski J; Turkiewicz D; Kałwak K; Pieczonka A; Boruczkowski D
    Przegl Lek; 2004; 61 Suppl 2():53-6. PubMed ID: 15686047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Posttransplant lymphoproliferative disorder after umbilical cord blood transplantation in children.
    Gong JZ; Bayerl MG; Sandhaus LM; Sebastian S; Rehder CW; Routbort M; Lagoo AS; Szabolcs P; Chiu J; Comito M; Buckley PJ
    Am J Surg Pathol; 2006 Mar; 30(3):328-36. PubMed ID: 16538052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early posttransplant lymphoproliferative disease in pediatric liver transplant recipients.
    Roque J; Rios G; Humeres R; Volpi C; Herrera JM; Schultz M; Rios H; Rius M; Salgado C; Hepp J
    Transplant Proc; 2006 Apr; 38(3):930-1. PubMed ID: 16647513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-transplantation lymphoproliferative disorders localizing to the gastrointestinal tract after liver transplantation: report of five pediatric cases.
    Lai YC; Ni YH; Jou ST; Ho MC; Wu JF; Chen HL; Hu RH; Jeng YM; Chang MH; Lee PH
    Pediatr Transplant; 2006 May; 10(3):390-4. PubMed ID: 16677368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diffuse lymphoproliferative disease after renal transplantation and its relation with Epstein-Barr virus. Experience at one center].
    Franco A; Jiménez L; Aranda I; Alvarez L; González M; Rocamora N; Olivares J
    Nefrologia; 2002; 22(5):463-9. PubMed ID: 12497748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased risk for posttransplant lymphoproliferative disease in recipients of liver transplants with hepatitis C.
    McLaughlin K; Wajstaub S; Marotta P; Adams P; Grant DR; Wall WJ; Jevnikar AM; Rizkalla KS
    Liver Transpl; 2000 Sep; 6(5):570-4. PubMed ID: 10980055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone marrow involvement in patients with posttransplant lymphoproliferative disorders: incidence and prognostic factors.
    Montanari F; O'Connor OA; Savage DG; Zain JM; Venkatraman S; McCormick EK; Crook MT; Tsao L; Sevilla DW; Bhagat G; Alobeid B
    Hum Pathol; 2010 Aug; 41(8):1150-8. PubMed ID: 20381113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term survival after post-transplant lymphoproliferative disease in children.
    Nathanson S; Debray D; Delarue A; Deschênes G
    Pediatr Nephrol; 2002 Aug; 17(8):668-72. PubMed ID: 12185479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of immunosuppression on posttransplant lymphoproliferative disease in pediatric liver transplant patients.
    Younes BS; McDiarmid SV; Martin MG; Vargas JH; Goss JA; Busuttil RW; Ament ME
    Transplantation; 2000 Jul; 70(1):94-9. PubMed ID: 10919581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver transplanted patients with preoperative autoimmune hepatitis and immunological disorders are at increased risk for Post-Transplant Lymphoproliferative Disease (PTLD).
    Zimmermann T; Hoppe-Lotichius M; Tripkovic V; Barreiros AP; Wehler TC; Zimmermann A; Schattenberg JM; Heise M; Biesterfeld S; Galle PR; Otto G; Schuchmann M
    Eur J Intern Med; 2010 Jun; 21(3):208-15. PubMed ID: 20493424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anthracycline-based chemotherapy as first-line treatment in adults with malignant posttransplant lymphoproliferative disorder after solid organ transplantation.
    Taylor AL; Bowles KM; Callaghan CJ; Wimperis JZ; Grant JW; Marcus RE; Bradley JA
    Transplantation; 2006 Aug; 82(3):375-81. PubMed ID: 16906036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rituximab therapy is effective for posttransplant lymphoproliferative disorders after solid organ transplantation: results of a phase II trial.
    Blaes AH; Peterson BA; Bartlett N; Dunn DL; Morrison VA
    Cancer; 2005 Oct; 104(8):1661-7. PubMed ID: 16149091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.